Reduction in ECMO mortality following increased experience : the Dubai Hospital experience
Background: Survival following extracorporeal membrane oxygenation (ECMO) has steadily improved over the past decade owing to better knowledge and training.1,2 The objective of our study is to identify the predictors and trend of in-hospital morbidity and mortality during our initial experience. Met...
Gespeichert in:
Veröffentlicht in: | Qatar medical journal 2017-02, Vol.2017 (1(s)), p.1-2 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2 |
---|---|
container_issue | 1(s) |
container_start_page | 1 |
container_title | Qatar medical journal |
container_volume | 2017 |
creator | Safadi, Fawzi al-Zamkan, Basil Abd al-Aziz, Tariq Sadiqi, Nayyir Khazi, Fayiz Muhammad al-Jasim, Ubayd Karali, Yahya Robert, Suresh |
description | Background: Survival following extracorporeal membrane
oxygenation (ECMO) has steadily improved
over the past decade owing to better knowledge and
training.1,2 The objective of our study is to identify
the predictors and trend of in-hospital morbidity and
mortality during our initial experience.
Methods: After obtaining an DSREC (Dubai Scientific
Research Ethics Committee) review and exemption,
we collected the clinical data of patients from May
2013 to November 2016 and analyzed for baseline
characteristics, indication, type, undergoing cardiopulmonary
resuscitation (CPR) or not, duration of
ECMO treatment, morbidity, and mortality.
Results: A total of 24 adults received ECMO (18 M/6
F), of which 22 were supported with veno-arterial
(VA) ECMO and the remaining were converted from
VA to veno-venous (VV) ECMO during the course of
their treatment. There were 8 (6 M/2 F) survivors
(30%) with two bridged for left ventricular assist
device (LVAD) and one for heart transplant. The
mortality pattern as shown in Figure 1 shows a
consistent improvement of more than 50% from mid-
2015. Weaning was overall successful in 30% of
surgical and 38% of medical patients. CPR was
necessary in 12 patients, none from the survivor
group. The minimum to maximum duration of ECMO
was 53–483 hours in the survivors versus 2–
528 hours in the non-survivors, of which 8 (50%)
survived less than 24 hours on ECMO. The most
frequent complications were bleeding from catheterization
or surgical site (58.3%), renal failure
(29.1%), GI bleeding (20.8%), and leg ischemia
(12.5%). Two patients had raised bilirubin and one
altered response to medication, resulting in hypertension
and bleeding.3 The percentage among
survivors to non-survivors with reference to bleeding Conclusions: In spite of a steep learning curve, a
remarkable improvement in the reduction of mortality
was achieved during the latter half of the term
possibly due to better understanding, education, and
training. The survival during this interval compared
well with the previous results and Extracorporeal Life
Support Organization (ELSO) reports.4,5 The percentage
of complications and the number of patients
requiring CPR were less in the survivors’ group,
indicating that early referral and prevention of ECMO
complications are equally important. These two
elements could be the key to our success in the
management of these patients. |
doi_str_mv | 10.5339/qmj.2017.swacelso.68 |
format | Article |
fullrecord | <record><control><sourceid>emarefa_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5474636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>790009</sourcerecordid><originalsourceid>FETCH-LOGICAL-b8018-98e55d9443659713868d003fa9cb5b474da1e43fcd64f9e090c8bfbb138e3ebc3</originalsourceid><addsrcrecordid>eNpVkNFKwzAUhoMoOKdvoJAX6EybNk28EGROJ0wGojfehCQ93TLapjadc29vxnTozTkX__l-Dh9ClzEZZZSK6496NUpInI_8RhmovBsxfoQGSZLkEUkTdowGJMloxMM4RWferwihjJFsgN5foFib3roG2wZPxs9zXLuuV5Xtt7h0VeU2tlmEzHSgPBQYvlroLDQG8A3ul4Dv11pZPHW-tQH7k5-jk1JVHi5-9hC9PUxex9NoNn98Gt_NIs1JzCPBIcsKkaaUZSKPKWe8CO-VShid6TRPCxVDSktTsLQUQAQxXJdah0ugoA0dott9b7vWNRQGmr5TlWw7W6tuK52y8n_S2KVcuE-ZhXJGWShI9wWmc953UB7YmMidYBkEy51g-StYMh6wqz0G4RZKdaByQQgR9Bs58H80</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reduction in ECMO mortality following increased experience : the Dubai Hospital experience</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Safadi, Fawzi ; al-Zamkan, Basil ; Abd al-Aziz, Tariq ; Sadiqi, Nayyir ; Khazi, Fayiz Muhammad ; al-Jasim, Ubayd ; Karali, Yahya ; Robert, Suresh</creator><creatorcontrib>Safadi, Fawzi ; al-Zamkan, Basil ; Abd al-Aziz, Tariq ; Sadiqi, Nayyir ; Khazi, Fayiz Muhammad ; al-Jasim, Ubayd ; Karali, Yahya ; Robert, Suresh</creatorcontrib><description>Background: Survival following extracorporeal membrane
oxygenation (ECMO) has steadily improved
over the past decade owing to better knowledge and
training.1,2 The objective of our study is to identify
the predictors and trend of in-hospital morbidity and
mortality during our initial experience.
Methods: After obtaining an DSREC (Dubai Scientific
Research Ethics Committee) review and exemption,
we collected the clinical data of patients from May
2013 to November 2016 and analyzed for baseline
characteristics, indication, type, undergoing cardiopulmonary
resuscitation (CPR) or not, duration of
ECMO treatment, morbidity, and mortality.
Results: A total of 24 adults received ECMO (18 M/6
F), of which 22 were supported with veno-arterial
(VA) ECMO and the remaining were converted from
VA to veno-venous (VV) ECMO during the course of
their treatment. There were 8 (6 M/2 F) survivors
(30%) with two bridged for left ventricular assist
device (LVAD) and one for heart transplant. The
mortality pattern as shown in Figure 1 shows a
consistent improvement of more than 50% from mid-
2015. Weaning was overall successful in 30% of
surgical and 38% of medical patients. CPR was
necessary in 12 patients, none from the survivor
group. The minimum to maximum duration of ECMO
was 53–483 hours in the survivors versus 2–
528 hours in the non-survivors, of which 8 (50%)
survived less than 24 hours on ECMO. The most
frequent complications were bleeding from catheterization
or surgical site (58.3%), renal failure
(29.1%), GI bleeding (20.8%), and leg ischemia
(12.5%). Two patients had raised bilirubin and one
altered response to medication, resulting in hypertension
and bleeding.3 The percentage among
survivors to non-survivors with reference to bleeding Conclusions: In spite of a steep learning curve, a
remarkable improvement in the reduction of mortality
was achieved during the latter half of the term
possibly due to better understanding, education, and
training. The survival during this interval compared
well with the previous results and Extracorporeal Life
Support Organization (ELSO) reports.4,5 The percentage
of complications and the number of patients
requiring CPR were less in the survivors’ group,
indicating that early referral and prevention of ECMO
complications are equally important. These two
elements could be the key to our success in the
management of these patients.</description><identifier>ISSN: 0253-8253</identifier><identifier>EISSN: 2227-0426</identifier><identifier>DOI: 10.5339/qmj.2017.swacelso.68</identifier><language>eng</language><publisher>Doha, Qatar: Hamad Medical Corporation</publisher><subject>الأكسجة الغشائية خارج الجسم ; المرضى ; مستشفى دبي ; معدل الوفيات</subject><ispartof>Qatar medical journal, 2017-02, Vol.2017 (1(s)), p.1-2</ispartof><rights>2017 Khazi, Aziz, Al-Zamkan, Safadi, Siddiqi, Karaly, Robert, Al-Jassim, licensee HBKU Press. 2017 HBKU Press.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b8018-98e55d9443659713868d003fa9cb5b474da1e43fcd64f9e090c8bfbb138e3ebc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474636/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474636/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Safadi, Fawzi</creatorcontrib><creatorcontrib>al-Zamkan, Basil</creatorcontrib><creatorcontrib>Abd al-Aziz, Tariq</creatorcontrib><creatorcontrib>Sadiqi, Nayyir</creatorcontrib><creatorcontrib>Khazi, Fayiz Muhammad</creatorcontrib><creatorcontrib>al-Jasim, Ubayd</creatorcontrib><creatorcontrib>Karali, Yahya</creatorcontrib><creatorcontrib>Robert, Suresh</creatorcontrib><title>Reduction in ECMO mortality following increased experience : the Dubai Hospital experience</title><title>Qatar medical journal</title><description>Background: Survival following extracorporeal membrane
oxygenation (ECMO) has steadily improved
over the past decade owing to better knowledge and
training.1,2 The objective of our study is to identify
the predictors and trend of in-hospital morbidity and
mortality during our initial experience.
Methods: After obtaining an DSREC (Dubai Scientific
Research Ethics Committee) review and exemption,
we collected the clinical data of patients from May
2013 to November 2016 and analyzed for baseline
characteristics, indication, type, undergoing cardiopulmonary
resuscitation (CPR) or not, duration of
ECMO treatment, morbidity, and mortality.
Results: A total of 24 adults received ECMO (18 M/6
F), of which 22 were supported with veno-arterial
(VA) ECMO and the remaining were converted from
VA to veno-venous (VV) ECMO during the course of
their treatment. There were 8 (6 M/2 F) survivors
(30%) with two bridged for left ventricular assist
device (LVAD) and one for heart transplant. The
mortality pattern as shown in Figure 1 shows a
consistent improvement of more than 50% from mid-
2015. Weaning was overall successful in 30% of
surgical and 38% of medical patients. CPR was
necessary in 12 patients, none from the survivor
group. The minimum to maximum duration of ECMO
was 53–483 hours in the survivors versus 2–
528 hours in the non-survivors, of which 8 (50%)
survived less than 24 hours on ECMO. The most
frequent complications were bleeding from catheterization
or surgical site (58.3%), renal failure
(29.1%), GI bleeding (20.8%), and leg ischemia
(12.5%). Two patients had raised bilirubin and one
altered response to medication, resulting in hypertension
and bleeding.3 The percentage among
survivors to non-survivors with reference to bleeding Conclusions: In spite of a steep learning curve, a
remarkable improvement in the reduction of mortality
was achieved during the latter half of the term
possibly due to better understanding, education, and
training. The survival during this interval compared
well with the previous results and Extracorporeal Life
Support Organization (ELSO) reports.4,5 The percentage
of complications and the number of patients
requiring CPR were less in the survivors’ group,
indicating that early referral and prevention of ECMO
complications are equally important. These two
elements could be the key to our success in the
management of these patients.</description><subject>الأكسجة الغشائية خارج الجسم</subject><subject>المرضى</subject><subject>مستشفى دبي</subject><subject>معدل الوفيات</subject><issn>0253-8253</issn><issn>2227-0426</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkNFKwzAUhoMoOKdvoJAX6EybNk28EGROJ0wGojfehCQ93TLapjadc29vxnTozTkX__l-Dh9ClzEZZZSK6496NUpInI_8RhmovBsxfoQGSZLkEUkTdowGJMloxMM4RWferwihjJFsgN5foFib3roG2wZPxs9zXLuuV5Xtt7h0VeU2tlmEzHSgPBQYvlroLDQG8A3ul4Dv11pZPHW-tQH7k5-jk1JVHi5-9hC9PUxex9NoNn98Gt_NIs1JzCPBIcsKkaaUZSKPKWe8CO-VShid6TRPCxVDSktTsLQUQAQxXJdah0ugoA0dott9b7vWNRQGmr5TlWw7W6tuK52y8n_S2KVcuE-ZhXJGWShI9wWmc953UB7YmMidYBkEy51g-StYMh6wqz0G4RZKdaByQQgR9Bs58H80</recordid><startdate>20170214</startdate><enddate>20170214</enddate><creator>Safadi, Fawzi</creator><creator>al-Zamkan, Basil</creator><creator>Abd al-Aziz, Tariq</creator><creator>Sadiqi, Nayyir</creator><creator>Khazi, Fayiz Muhammad</creator><creator>al-Jasim, Ubayd</creator><creator>Karali, Yahya</creator><creator>Robert, Suresh</creator><general>Hamad Medical Corporation</general><general>HBKU Press</general><scope>AACQA</scope><scope>ADJCN</scope><scope>AEION</scope><scope>AHFXO</scope><scope>AHHHR</scope><scope>AHQOB</scope><scope>AKWCH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20170214</creationdate><title>Reduction in ECMO mortality following increased experience : the Dubai Hospital experience</title><author>Safadi, Fawzi ; al-Zamkan, Basil ; Abd al-Aziz, Tariq ; Sadiqi, Nayyir ; Khazi, Fayiz Muhammad ; al-Jasim, Ubayd ; Karali, Yahya ; Robert, Suresh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b8018-98e55d9443659713868d003fa9cb5b474da1e43fcd64f9e090c8bfbb138e3ebc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>الأكسجة الغشائية خارج الجسم</topic><topic>المرضى</topic><topic>مستشفى دبي</topic><topic>معدل الوفيات</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Safadi, Fawzi</creatorcontrib><creatorcontrib>al-Zamkan, Basil</creatorcontrib><creatorcontrib>Abd al-Aziz, Tariq</creatorcontrib><creatorcontrib>Sadiqi, Nayyir</creatorcontrib><creatorcontrib>Khazi, Fayiz Muhammad</creatorcontrib><creatorcontrib>al-Jasim, Ubayd</creatorcontrib><creatorcontrib>Karali, Yahya</creatorcontrib><creatorcontrib>Robert, Suresh</creatorcontrib><collection>بنك معلومات "معرفة" لدراسات العلوم العسكرية والأمنية - e-Marefa Military & Security Database</collection><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>مجلس التعاون الخليجي وإيران - e-Marefa The GCC-Iranian Affairs</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>دراسات الشرق الأوسط - e-Marefa Middle Eastern Studies</collection><collection>الشؤون الدولية والعربية - e-Marefa International & Arab Affairs</collection><collection>أوراق المؤتمرات - e-Marefa Conference Papers</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Qatar medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Safadi, Fawzi</au><au>al-Zamkan, Basil</au><au>Abd al-Aziz, Tariq</au><au>Sadiqi, Nayyir</au><au>Khazi, Fayiz Muhammad</au><au>al-Jasim, Ubayd</au><au>Karali, Yahya</au><au>Robert, Suresh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction in ECMO mortality following increased experience : the Dubai Hospital experience</atitle><jtitle>Qatar medical journal</jtitle><date>2017-02-14</date><risdate>2017</risdate><volume>2017</volume><issue>1(s)</issue><spage>1</spage><epage>2</epage><pages>1-2</pages><issn>0253-8253</issn><eissn>2227-0426</eissn><abstract>Background: Survival following extracorporeal membrane
oxygenation (ECMO) has steadily improved
over the past decade owing to better knowledge and
training.1,2 The objective of our study is to identify
the predictors and trend of in-hospital morbidity and
mortality during our initial experience.
Methods: After obtaining an DSREC (Dubai Scientific
Research Ethics Committee) review and exemption,
we collected the clinical data of patients from May
2013 to November 2016 and analyzed for baseline
characteristics, indication, type, undergoing cardiopulmonary
resuscitation (CPR) or not, duration of
ECMO treatment, morbidity, and mortality.
Results: A total of 24 adults received ECMO (18 M/6
F), of which 22 were supported with veno-arterial
(VA) ECMO and the remaining were converted from
VA to veno-venous (VV) ECMO during the course of
their treatment. There were 8 (6 M/2 F) survivors
(30%) with two bridged for left ventricular assist
device (LVAD) and one for heart transplant. The
mortality pattern as shown in Figure 1 shows a
consistent improvement of more than 50% from mid-
2015. Weaning was overall successful in 30% of
surgical and 38% of medical patients. CPR was
necessary in 12 patients, none from the survivor
group. The minimum to maximum duration of ECMO
was 53–483 hours in the survivors versus 2–
528 hours in the non-survivors, of which 8 (50%)
survived less than 24 hours on ECMO. The most
frequent complications were bleeding from catheterization
or surgical site (58.3%), renal failure
(29.1%), GI bleeding (20.8%), and leg ischemia
(12.5%). Two patients had raised bilirubin and one
altered response to medication, resulting in hypertension
and bleeding.3 The percentage among
survivors to non-survivors with reference to bleeding Conclusions: In spite of a steep learning curve, a
remarkable improvement in the reduction of mortality
was achieved during the latter half of the term
possibly due to better understanding, education, and
training. The survival during this interval compared
well with the previous results and Extracorporeal Life
Support Organization (ELSO) reports.4,5 The percentage
of complications and the number of patients
requiring CPR were less in the survivors’ group,
indicating that early referral and prevention of ECMO
complications are equally important. These two
elements could be the key to our success in the
management of these patients.</abstract><cop>Doha, Qatar</cop><pub>Hamad Medical Corporation</pub><doi>10.5339/qmj.2017.swacelso.68</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0253-8253 |
ispartof | Qatar medical journal, 2017-02, Vol.2017 (1(s)), p.1-2 |
issn | 0253-8253 2227-0426 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5474636 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | الأكسجة الغشائية خارج الجسم المرضى مستشفى دبي معدل الوفيات |
title | Reduction in ECMO mortality following increased experience : the Dubai Hospital experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A17%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-emarefa_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20in%20ECMO%20mortality%20following%20increased%20experience%20:%20the%20Dubai%20Hospital%20experience&rft.jtitle=Qatar%20medical%20journal&rft.au=Safadi,%20Fawzi&rft.date=2017-02-14&rft.volume=2017&rft.issue=1(s)&rft.spage=1&rft.epage=2&rft.pages=1-2&rft.issn=0253-8253&rft.eissn=2227-0426&rft_id=info:doi/10.5339/qmj.2017.swacelso.68&rft_dat=%3Cemarefa_pubme%3E790009%3C/emarefa_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |